Pharma Blog Review » Uncategorized

Archive for the ‘ Uncategorized ’ Category

Squeezed between meetings …

Friday, November 21st, 2008

It's been a busy week for me in and out of the office (I've had two days of this week full of meetings and today will be a meetings marathon). This week was also a busy one in terms of news. President-elect Barack Obama is tapping Sen. Tom Daschle as ...

Posted in Uncategorized | No Comments »

Another day, another meeting

Thursday, November 20th, 2008

Just a little note to add to the week before I do the blog review. It's been a particularly meeting-heavy week, and I was in Princeton Thursday to listen in on a discussion of social media and the pharmaceutical industry. The meeting attendees were mostly ad executives and technology people; ...

Posted in Uncategorized | No Comments »

Jupiter’s gravity, and a brewing political battle

Friday, November 14th, 2008

Sort of a slow week, but interesting things did happen. The biggest news of the week was the results of AstraZeneca's Jupiter study, and everyone seems to be debating about how the results will affect Crestor sales and the use of statins (even as some say it's a boost, CEO ...

Posted in Uncategorized | No Comments »

A new president, a look at the future, but the world goes on

Friday, November 7th, 2008

Yes, Barack Hussein Obama will be the 44th president of the United States, once he is sworn into office in January. Now that the election is over and Mr. Obama is already starting to pick staff members, we can all go back to our daily lives. Other things did happen ...

Posted in Uncategorized | 1 Comment »

Science ignorance, Avandia attacked again, and more about pre-emption

Friday, October 31st, 2008

Yes, it's Halloween today. Hopefully you will find this roundup full of treats, not tricks. PharmaGossip knows how to celebrate (do you recognize anyone?). This was a fairly quiet week, as the countdown narrows for the U.S. presidential elections. There was some interesting news: Wyeth, like many other pharma companies, ...

Posted in Uncategorized | 2 Comments »

Merck job cuts, Acomplia sales suspended, and other bits

Friday, October 24th, 2008

It started off as a nice quiet week, but then Merck reported that it would be shedding 7,200 jobs and closing three research labs, with 40% of the job cuts coming from the United States. Europe suspended sales of the antiobesity drug Acomplia. And the New York Times reported that ...

Posted in Uncategorized | No Comments »